ProXara Biotechnology Ltd
ProXara Biotechnology Ltd is a cell-based drug discovery company that has identified proprietary drug-like molecules for the treatment of cancer, particularly prostate and breast. These act by inhibiting intracellular signalling, including protein kinase activation, via a novel mechanism of action. Currently in hit-to-lead optimisation, the company expects to lead compounds to be ready for pre-clinical development during 2006-7. ProXara has a strong, entrepreneurial and commercially experienced management team, which is seeking to grow the company rapidly through merger and acquisition opportunities.
Contact: Dr Paul England, Chief Operating Officer
Email: info@proxara.com